DuPont/Bunge soy alliance
This article was originally published in The Tan Sheet
Executive Summary
Joint venture Solae will focus on production of specialty proteins including soy concentrates, lecithins and isolates, partners DuPont and agribusiness company Bunge report. Firms anticipate annual revenues of more than $800 mil. for venture. St. Louis-based Solae is expected to launch this spring...
You may also be interested in...
ADM buys Solae’s soy
Decatur, Ill.-based Archer Daniels Midland has purchased Solae's soy isoflavone business, the firms announce Feb. 15. The acquisition includes "an extensive portfolio of U.S. patents, numerous foreign equivalents and pending applications," ADM says. The deal was reached under a settlement in an isoflavone concentrate patent infringement lawsuit Solae filed against ADM in 2003. Solae was created as a joint venture between Dupont and Bunge in January 2003 (1"The Tan Sheet" Jan. 20, 2003, In Brief)...
ADM’s Novasoy, Amerifit’s Estroven Allegedly Infringe Solae Patents
Solae is seeking to permanently enjoin Archer Daniels Midland and Amerifit Nutrition from making, using or selling soy products it believes infringe on certain company-owned patents, according to a June 3 complaint
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.